Nasdaq 100 logs its steepest weekly drop since the 2020 pandemic selloff
U.S. stocks plunged Friday, with the Nasdaq 100 posting its worst week since March 2020, as AI shares tumbled and the S&P 500 fell for a seventh straight day.
Anthropic shares fell to $87.63 in premarket, approaching the $83 IPO price, as the AI sector weakens.
Anthropic shares are moving lower, approaching the $83 mark. The question is whether financial institutions have a reason to defend the initial public offering price.
The stock has given back most of its spectacular first-day gains as the AI sector faces pressure. Examining the company's funding background, SEC filings and after-hours trading shows why $83 is a key level, though institutional backing is not assured.
On November 20, 2026, Anthropic (NASDAQ: ANT) traded around $87.63 in the premarket session, about 9.8% below Thursday's close of $97.17.
The drop raises a question for traders and investors: do the institutions involved in the largest IPO ever have an incentive to protect the $83 offering price?
There are reasons to focus on that level. However, recent price action suggests buyers have not yet taken control.
From $115 to below $88 in less than a day
Anthropic's first trading day on November 19 started with extraordinary excitement.
The Claude AI developer priced its IPO at $83 per share, above the original $70-$78 marketing range, raising roughly $81.34 billion. That gave a fully diluted valuation of about $1.5 trillion.
The shares opened at $111.50, hit $115.10 and ended at $97.17.
While that close was 17.1% above the offering price, buyers who entered near the first-day high had already seen a big reversal.
By Friday's premarket low near $87.31, the stock had lost about 24% from Thursday's peak.
This marks a key difference between a successful IPO for those who got shares at $83 and the experience of buyers who entered after public trading began.
Someone who bought at the $111.50 opening would face a paper loss of roughly 21% at the $87.63 premarket quote, while IPO participants allocated at $83 would still be ahead.
What the five-minute chart reveals about the overnight selloff
The detailed overnight price action adds another useful observation.
Anthropic did not simply fall in one straight line from Thursday's close.
During the evening and overnight session, the stock tried repeatedly to stabilize around $90-$92. Several recoveries occurred, including a bounce toward $92.41 around 3:30 a.m. Eastern Time and another push toward $92 around 5:30 a.m.
Neither attempt produced a lasting recovery.
More importantly, the character of the decline changed in the final hour of the observed premarket period.
Around 6:25 a.m. Eastern, the stock was still near $90.67. By about 6:30 a.m., it had broken lower, and selling drove it toward $87.31 by 7:20 a.m.
That is a drop of roughly 3.7% from the earlier $90.67 reference to the low in less than an hour.
The new information is that repeated stabilization attempts were followed by an accelerating decline, rather than the formation of a convincing recovery.
This does not identify who was selling. Extended-hours trading can also be less liquid and more volatile than the regular Nasdaq session.
Nevertheless, it makes the next trading session particularly interesting.
The $90-$91 area, which attracted repeated recovery attempts overnight, could become a useful near-term reference if buyers try to regain control. The previous regular session low at $92.72 is another resistance level above.
Why the $83 IPO price matters to institutional investors
Anthropic's final SEC prospectus contains a detail that makes the $83 offering price especially relevant.
Morgan Stanley, acting as stabilization agent for the underwriting syndicate, is allowed to undertake certain transactions intended to stabilize or support the market price after the offering.
The underwriting agreement also includes an option to buy up to 147 million additional shares at the IPO price of $83, exercisable for 30 days.
Here is why that matters.
Underwriters sometimes sell additional shares as part of an IPO distribution, creating a short position they later need to cover.
If the stock trades below the offering price, buying shares in the open market may be more attractive than exercising the option to purchase additional shares at $83.
Such purchases can potentially support the share price.
But there is no obligation for the underwriters to defend $83 or any other price. The prospectus explicitly allows stabilization activities to end at any time.
Thus, $83 is a documented institutional reference price, not a guaranteed market floor.
The other $26 billion reason to watch $83
The public IPO was paired with a separate $26 billion strategic private placement at the same $83 price.
According to Anthropic's SEC filings, the investors included:
Google and Nvidia, each committing approximately $10 billion.
AMD, committing approximately $2.5 billion.
Broadcom, Micron and Microsoft, each committing approximately $1 billion.
TSMC, committing approximately $500 million.
These commitments make $83 a significant economic reference for some of the world's largest technology companies.
However, these investors may view their Anthropic stakes as long-term strategic investments related to cloud computing, AI infrastructure and commercial relationships.
A strategic investor's entry price does not necessarily create an incentive to intervene in the secondary market whenever the stock falls.
There is another counterweight. The prospectus indicates that up to 315 million shares could become eligible for sale starting shortly after the offering, subject to applicable conditions and restrictions. Eligibility does not mean any of these shares have actually been sold, but it illustrates why potential supply must also be considered.
What about Anthropic's valuation before the IPO?
Another useful reference comes from Anthropic's final major private financing.
In May 2026, the company announced a $65 billion Series H funding round at a post-money valuation of roughly $965 billion.
The financing included preferred shares bought at $589.0095 each. After conversion into ten common shares, the equivalent purchase price was about $58.90 per common share.
That is well below the $83 IPO price.
Consequently, investors who participated in that private round may still have large unrealized gains, even if Anthropic trades below its public offering price. Their securities, rights and liquidity restrictions may also differ from those of ordinary public shareholders.
This creates an important distinction:
The $83 level matters to new IPO participants and the underwriting arrangements. The roughly $58.90 equivalent price represents an earlier private financing cost basis, not immediate technical support.
Neither establishes what Anthropic must be worth in the public market today.
Anthropic stock: The important prices to watch next
$92.72: The first trading day's low
Friday's premarket decline has already moved below this level. A recovery above it, followed by sustained trading, would be a more constructive sign that buyers are rebuilding confidence.
$90-$91: An overnight stabilization area that weakened
Several attempted recoveries occurred around this area before the sharper decline. If ANT recovers, whether it can regain and hold this territory may provide an early indication of improving short-term demand.
$83: The central IPO price reference
This is the most important level in the institutional-support discussion. It is the actual price paid by public IPO participants and the reference price for the concurrent strategic placement and underwriting option.
A recovery after testing this level would be worth watching. But a brief touch and rebound would not, by itself, prove institutional buying or establish durable support.
$70-$78: The original IPO marketing range
If $83 fails, the original offering range becomes a relevant historical valuation reference. These were proposed pricing levels before the actual offering, however, and should not automatically be treated as established technical support.
What would suggest that $83 is being defended?
The more constructive scenario would involve ANT approaching the IPO price, experiencing a slowing decline and subsequently recovering with sustained buying interest.
A successful retest, followed by recovery through some of the previously lost trading areas, would add evidence that market participants are willing to accept prices above the offering level.
The less constructive scenario would involve the stock falling below $83, failing to reclaim it and continuing lower.
That would raise questions about whether the enormous institutional commitments made around the IPO are translating into meaningful secondary-market demand.
It is also possible for underwriting-related purchases to temporarily slow a decline without generating a lasting recovery. Once those purchases end, independent investors must provide sufficient demand.
This distinction matters particularly because the broader AI sector is experiencing selling pressure. As investingLive reported during Thursday's session, Anthropic's record IPO did not prevent weakness across major US equity indices.
The important lesson for investors
Anthropic's $83 offering price deserves attention because it represents a substantial, documented financial transaction involving major institutions, technology companies and Wall Street underwriters.
It is more meaningful than an arbitrary round number on a chart.
But a reason for institutions to care about a price is not proof that they will defend it.
For traders, the more useful question is whether the market begins demonstrating genuine demand as ANT approaches this level.
For longer-term investors, another question is equally important: does Anthropic's business outlook justify its valuation independently of where the IPO was priced?
These are two different considerations, and both deserve attention.
At the observed premarket price near $87.63, the $83 offering price was only about 5.3% lower. That makes the potential test relevant, but not inevitable.
Patience may be particularly valuable in a newly listed stock experiencing large price swings. An apparently attractive price can become considerably less attractive if selling pressure continues.
Market analysis reflects the November 20, 2026 premarket snapshot around 7:24 a.m. Eastern Time, before the US regular trading session. Price levels are conditional observations, not guaranteed support or trade recommendations.
Share to
Disclaimer: this article comes from third-party media and is provided for reference only. It does not constitute investment advice. Crypto and other financial products carry significant price volatility risk, so please make your own decisions carefully.
U.S. stocks plunged Friday, with the Nasdaq 100 posting its worst week since March 2020, as AI shares tumbled and the S&P 500 fell for a seventh straight day.
The S&P 500 slipped below 7,000 after reports of an SEC accounting probe into Nvidia, whose shares tumbled 12%.
Nvidia shares slid after reports of an SEC accounting probe, while the Nasdaq Composite and Nasdaq 100 indexes also fell.
European stock markets ended the week sharply lower. The DAX fell 7.29%, its worst week since March 2025.